BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frickenstein AN, Hagood JM, Britten CN, Abbott BS, McNally MW, Vopat CA, Patterson EG, MacCuaig WM, Jain A, Walters KB, McNally LR. Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics 2021;13:570. [PMID: 33920503 DOI: 10.3390/pharmaceutics13040570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Maccuaig WM, Samykutty A, Foote J, Luo W, Filatenkov A, Li M, Houchen C, Grizzle WE, Mcnally LR. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022;14:969. [DOI: 10.3390/pharmaceutics14050969] [Reference Citation Analysis]
3 Gao Y, Zhang Y, Hong Y, Wu F, Shen L, Wang Y, Lin X. Multifunctional Role of Silica in Pharmaceutical Formulations. AAPS PharmSciTech 2022;23:90. [PMID: 35296944 DOI: 10.1208/s12249-022-02237-5] [Reference Citation Analysis]
4 Filippov SK, Khusnutdinov RR, Inham W, Liu C, Nikitin DO, Semina II, Garvey CJ, Nasibullin SF, Khutoryanskiy VV, Zhang H, Moustafine RI. Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum? Polymers (Basel) 2021;13:4189. [PMID: 34883693 DOI: 10.3390/polym13234189] [Reference Citation Analysis]
5 Otalvaro JO, Álvarez TR, Gurovic MSV, Lassalle V, Agotegaray M, Avena M, Brigante M. Magnetic mesoporous silica nanoparticles for drug delivery systems: Synthesis, characterization and application as norfloxacin carrier. J Pharm Sci 2022:S0022-3549(22)00244-1. [PMID: 35667632 DOI: 10.1016/j.xphs.2022.05.024] [Reference Citation Analysis]
6 Zhang C, Zhu X, Hou S, Pan W, Liao W. Functionalization of Nanomaterials for Skin Cancer Theranostics. Front Bioeng Biotechnol 2022;10:887548. [DOI: 10.3389/fbioe.2022.887548] [Reference Citation Analysis]
7 Zhang X, Zhu Y, Fan L, Ling J, Yang LY, Wang N, Ouyang XK. Delivery of curcumin by fucoidan-coated mesoporous silica nanoparticles: Fabrication, characterization, and in vitro release performance. Int J Biol Macromol 2022;211:368-79. [PMID: 35577185 DOI: 10.1016/j.ijbiomac.2022.05.086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Du W, Gao Y, Liu L, Sai S, Ding C. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies. Int J Mol Sci 2021;22:10104. [PMID: 34576268 DOI: 10.3390/ijms221810104] [Reference Citation Analysis]
9 Ren S, Wang M, Wang C, Wang Y, Sun C, Zeng Z, Cui H, Zhao X. Application of Non-Viral Vectors in Drug Delivery and Gene Therapy. Polymers (Basel) 2021;13:3307. [PMID: 34641123 DOI: 10.3390/polym13193307] [Reference Citation Analysis]
10 MacCuaig WM, Fouts BL, McNally MW, Grizzle WE, Chuong P, Samykutty A, Mukherjee P, Li M, Jasinski JB, Behkam B, McNally LR. Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces 2021;13:49614-30. [PMID: 34653338 DOI: 10.1021/acsami.1c09379] [Reference Citation Analysis]
11 Dennahy IS, Han Z, Maccuaig WM, Chalfant HM, Condacse A, Hagood JM, Claros-sorto JC, Razaq W, Holter-chakrabarty J, Squires R, Edil BH, Jain A, Mcnally LR. Nanotheranostics for Image-Guided Cancer Treatment. Pharmaceutics 2022;14:917. [DOI: 10.3390/pharmaceutics14050917] [Reference Citation Analysis]